Mortality secondary to thromboembolism within 30 days of surgery – not reported · people with a low platelet count
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality secondary to infection within 30 days of surgery – not reported · people with a low platelet count
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants with major bleeding within 7 days of surgery (surgical site bleeding requiring a second intervention or reoperation or surgical site bleeding that causes a haematoma or haemarthrosis of sufficient size to delay mobilisation ... · people with a low platelet count
It is very uncertain whether prophylactic platelet transfusion prior to surgery changes number of participants with major bleeding within 7 days of surgery… compared with no prophylactic platelet transfusion prior to surgery (very low certainty).
1 finding from 1 review
Number of participants with minor procedure‐related bleeding within 7 days of surgery · people with a low platelet count
It is very uncertain whether prophylactic platelet transfusion prior to surgery changes the number of participants with minor procedure‐related bleeding… compared with no prophylactic platelet transfusion prior to surgery (very low certainty).
1 finding from 1 review
Serious adverse events (surgery‐related adverse effects within 30 days) · people with a low platelet count
1 finding from 1 review
All‐cause mortality within 30 days of surgery – not reported · people with a low platelet count
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality secondary to bleeding within 30 days of surgery – not reported · people with a low platelet count
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from all causes during treatment (range 6 days to 16 days) · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in death from all causes during treatment (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Deep vein thrombosis · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids may leads to lower deep vein thrombosis during treatment period (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Pulmonary embolism · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in pulmonary embolism during treatment period (range 6 days to 16 days) compared with unfractionated heparin (low certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage/haemorrhagic transformation of the cerebral infarct during treatment period (range 6 days to 16 days)⁹ · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in symptomatic intracranial haemorrhage/haemorrhagic transformation of… compared with unfractionated heparin (low certainty).
1 finding from 1 review
Death or dependency · people with acute stroke
Glyceryl trinitrate (GTN) showed no clear difference in death or dependency (mRS>2), end of trial (90 days) compared with no GTN (high certainty).
1 finding from 1 review
Death by end of trial · people with acute stroke
Glyceryl trinitrate (GTN) showed no clear difference in death, end of trial (90 days) compared with no GTN (high certainty).
1 finding from 1 review
Quality of life, end of trial (90 days) · people with acute stroke
1 finding from 1 review
Adverse effects: headache · people with acute stroke
Glyceryl trinitrate (GTN) leads to higher adverse event: Headache, on treatment (7‐12 days) compared with no GTN (high certainty).
1 finding from 1 review
Intervention not reported
Change in total calories (Kcal/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total protein (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Change in total fat (g/day): at 12 months · adults and children with cystic fibrosis
1 finding from 1 review
Intervention not reported
Length of initial hospital stay (days) · people with stroke
The intervention probably leads to higher length of initial hospital stay (days) (moderate certainty).
1 finding from 1 review
Mortality before hospital discharge · respiratory failure in preterm infants
Inhaled NO showed no clear difference in death before discharge ‐ Studies with entry before 3 days based on… compared with control (high certainty).
2 findings from 1 review